Incidental Mutation 'R5522:Vmn2r40'
ID 431611
Institutional Source Beutler Lab
Gene Symbol Vmn2r40
Ensembl Gene ENSMUSG00000090864
Gene Name vomeronasal 2, receptor 40
Synonyms
MMRRC Submission 043081-MU
Accession Numbers
Essential gene? Not available question?
Stock # R5522 (G1)
Quality Score 100
Status Not validated
Chromosome 7
Chromosomal Location 8910733-8934401 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) T to A at 8911203 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Threonine to Serine at position 697 (T697S)
Gene Model predicted gene model for transcript(s): [ENSMUST00000171942]
AlphaFold F6W043
Predicted Effect probably benign
Transcript: ENSMUST00000169206
AA Change: T697S

PolyPhen 2 Score 0.296 (Sensitivity: 0.91; Specificity: 0.89)
SMART Domains Protein: ENSMUSP00000131780
Gene: ENSMUSG00000090864
AA Change: T697S

DomainStartEndE-ValueType
signal peptide 1 18 N/A INTRINSIC
low complexity region 59 71 N/A INTRINSIC
Pfam:ANF_receptor 73 469 4.8e-32 PFAM
Pfam:NCD3G 512 565 1.1e-20 PFAM
Pfam:7tm_3 598 833 3.7e-54 PFAM
Predicted Effect unknown
Transcript: ENSMUST00000171942
AA Change: T697S
SMART Domains Protein: ENSMUSP00000132332
Gene: ENSMUSG00000090864
AA Change: T697S

DomainStartEndE-ValueType
signal peptide 1 18 N/A INTRINSIC
low complexity region 59 71 N/A INTRINSIC
Pfam:ANF_receptor 73 468 2.2e-32 PFAM
Pfam:NCD3G 512 565 6.1e-17 PFAM
Pfam:7tm_3 547 784 1.6e-78 PFAM
Coding Region Coverage
  • 1x: 99.0%
  • 3x: 97.4%
  • 10x: 93.9%
  • 20x: 85.3%
Validation Efficiency
Allele List at MGI
Other mutations in this stock
Total: 58 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Adgrl1 T C 8: 84,649,704 (GRCm39) Y121H possibly damaging Het
Agbl5 G A 5: 31,051,247 (GRCm39) probably null Het
Atp13a2 T A 4: 140,731,671 (GRCm39) probably null Het
Cd69 A T 6: 129,248,379 (GRCm39) S36T probably damaging Het
Ceacam5 A T 7: 17,449,005 (GRCm39) I124L probably benign Het
Cerkl T C 2: 79,223,328 (GRCm39) H131R probably benign Het
Cfap57 A T 4: 118,453,085 (GRCm39) N539K probably benign Het
Cyp4x1 C A 4: 114,979,174 (GRCm39) W141L probably damaging Het
Dlgap1 T C 17: 70,823,993 (GRCm39) probably null Het
Dnaaf9 G A 2: 130,656,222 (GRCm39) probably benign Het
Dst T C 1: 34,296,954 (GRCm39) I5781T possibly damaging Het
Epha2 T A 4: 141,035,867 (GRCm39) V101E probably damaging Het
Exph5 T C 9: 53,285,613 (GRCm39) F898S possibly damaging Het
Fyco1 G A 9: 123,623,836 (GRCm39) R1398* probably null Het
Gemin6 T G 17: 80,535,178 (GRCm39) V46G probably damaging Het
Grb10 T C 11: 11,886,746 (GRCm39) I508V probably benign Het
Igf1r C A 7: 67,833,258 (GRCm39) Q473K probably damaging Het
Ighv1-66 T A 12: 115,556,755 (GRCm39) D109V probably damaging Het
Ipmk C A 10: 71,199,304 (GRCm39) T55K probably benign Het
Kdm2b A G 5: 123,087,225 (GRCm39) Y192H probably damaging Het
Krt32 A T 11: 99,977,497 (GRCm39) probably null Het
Kti12 T A 4: 108,705,620 (GRCm39) L178Q possibly damaging Het
Mchr1 A T 15: 81,122,211 (GRCm39) K320N possibly damaging Het
Mdn1 T C 4: 32,685,783 (GRCm39) L858S probably damaging Het
Myo3a T A 2: 22,464,353 (GRCm39) F198Y probably damaging Het
Ncam2 C T 16: 81,231,766 (GRCm39) R77* probably null Het
Nfatc1 T C 18: 80,696,744 (GRCm39) T647A probably benign Het
Nuf2 A G 1: 169,326,453 (GRCm39) Y433H probably damaging Het
Nup210l T C 3: 90,061,972 (GRCm39) V717A probably benign Het
Or3a1b A G 11: 74,012,484 (GRCm39) Y123C probably damaging Het
Or5h17 A T 16: 58,820,268 (GRCm39) L73F probably benign Het
Or6c35 A T 10: 129,168,798 (GRCm39) D16V probably damaging Het
Pbrm1 A G 14: 30,811,520 (GRCm39) Y1210C probably damaging Het
Pcdhb6 A G 18: 37,467,402 (GRCm39) I108V probably benign Het
Plac8 T A 5: 100,710,584 (GRCm39) T6S probably benign Het
Plbd1 A T 6: 136,594,298 (GRCm39) V317E probably benign Het
Rars1 A T 11: 35,708,195 (GRCm39) Y406* probably null Het
Scamp3 T C 3: 89,084,929 (GRCm39) F11L possibly damaging Het
Sctr A G 1: 119,964,146 (GRCm39) N142S probably benign Het
Sh2d4a T C 8: 68,749,349 (GRCm39) S128P probably benign Het
Snrnp70 C T 7: 45,026,601 (GRCm39) probably benign Het
Taf3 T C 2: 9,945,816 (GRCm39) K596R probably damaging Het
Tango6 T C 8: 107,422,230 (GRCm39) probably null Het
Taok3 A G 5: 117,411,822 (GRCm39) T414A probably benign Het
Tmem104 G A 11: 115,079,149 (GRCm39) probably null Het
Tmem231 T A 8: 112,645,042 (GRCm39) S155C possibly damaging Het
Tssk3 G A 4: 129,383,343 (GRCm39) R110W possibly damaging Het
Ugt2b37 T C 5: 87,388,759 (GRCm39) T485A probably benign Het
Unc5b T C 10: 60,613,974 (GRCm39) K292E possibly damaging Het
Upf3a T A 8: 13,845,497 (GRCm39) probably null Het
Usp24 T A 4: 106,229,918 (GRCm39) V797E probably damaging Het
Vcan T C 13: 89,839,929 (GRCm39) T1872A possibly damaging Het
Vmn1r195 A G 13: 22,463,120 (GRCm39) M197V probably damaging Het
Xab2 A T 8: 3,661,718 (GRCm39) D578E probably benign Het
Xpo7 A T 14: 70,909,090 (GRCm39) Y810* probably null Het
Zcchc2 A G 1: 105,951,426 (GRCm39) N587S probably benign Het
Zfp189 C T 4: 49,529,739 (GRCm39) R281* probably null Het
Zranb1 T C 7: 132,585,678 (GRCm39) *735R probably null Het
Other mutations in Vmn2r40
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01018:Vmn2r40 APN 7 8,911,175 (GRCm39) missense probably damaging 0.97
IGL01678:Vmn2r40 APN 7 8,923,105 (GRCm39) missense probably damaging 0.99
IGL03373:Vmn2r40 APN 7 8,923,092 (GRCm39) missense probably benign 0.00
R4996:Vmn2r40 UTSW 7 8,911,166 (GRCm39) missense probably damaging 1.00
R6767:Vmn2r40 UTSW 7 8,923,139 (GRCm39) missense unknown
R6785:Vmn2r40 UTSW 7 8,911,203 (GRCm39) missense probably benign 0.30
R7631:Vmn2r40 UTSW 7 8,911,119 (GRCm39) missense
R7714:Vmn2r40 UTSW 7 8,911,116 (GRCm39) missense
R8053:Vmn2r40 UTSW 7 8,911,245 (GRCm39) missense
R8298:Vmn2r40 UTSW 7 8,911,148 (GRCm39) missense
R8544:Vmn2r40 UTSW 7 8,911,191 (GRCm39) missense
R8894:Vmn2r40 UTSW 7 8,923,197 (GRCm39) missense
R9093:Vmn2r40 UTSW 7 8,911,172 (GRCm39) missense
Predicted Primers PCR Primer
(F):5'- TGCAGGCCAAATATCCCAGG -3'
(R):5'- TGACACTCCTATTGTGAAGGC -3'

Sequencing Primer
(F):5'- CCCAGGATACAGTAGAATGCAGTATC -3'
(R):5'- CTCCTATTGTGAAGGCCAATAACAG -3'
Posted On 2016-10-05